Single agent paclitaxel in the treatment of unresectable and/or metastatic pancreatic adenocarcinoma

European Journal of Cancer Part A

Volumn 32, Issue 10, 1996, Pages 1821-

  Gebbia, N ^a   Gebbia, V ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33748459642     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Wagener DJT, de Mulder PHM, Wils JA. Multimodality treatment of locally advanced pancreatic cancer. Ann Oncol 1994, 5 (Suppl. 3), S81-S86.
2. lionetto R, Pugliese V, Bruzzi P, Rosso R. No standard treatment is available for advanced pancreatic cancer. Eur J Cancer 1995, 31A, 882-887.
3. McGuire WP, Rowinsky EK, Rosenhein NB. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasm. Ann Intern Med 1989, 111, 273-279.
4. Horwitz SB. Taxol (paclitaxel): mechanisms of action. Ann Oncol 1994, 5 (Suppl. 6), S3-S6.
5. Rowinsky EK, Cazenave LA, Donehower RC. Taxol: a novel investigational antimicrotubule agent. J Nad Cancer Inst 1990, 82, 1247-1259.
6. De Greve J, Vergeleylen A, Vandame B, Egawa N, Vandervoude K, Schallier D, Kloppel G. Preclinical activity of paclitaxel against human pancreatic cancer. Proc Am Soc Clin Oncol 1194, 13, 217 (Abstract).
7. Miller AB, Hoogtrstaen B, Staquet M, Winkler M. Reporting results of cancer treatment. Cancer 1981, 47, 207-214.
8. Gehan EA. The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. J Chron Dis 1961, 13, 146-153.
9. Muggia FM. Clinical activity in other tumors. In McGuire WP, Rowinsky EK, eds. Paclitaxel in Cancer Treatment. New York, Marcel Dekker, 1995, 329-338.